Drug recall
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC…
FDA recall event 89968 · Class II · RemedyRepack Inc.
Key facts
| Event ID | 89968 |
|---|---|
| Recall numbers | D-0788-2022 |
| Recalling firm | RemedyRepack Inc. |
| Product type | Drugs |
| Products | Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202. |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits. |
| Initiation date | Apr 6, 2022 |
| Report date | May 4, 2022 |
| Termination date | May 27, 2022 |
| City | Indiana |
| State | PA |
| Country | United States |
| FEI number | 3005841768 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: